Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01961232 · ClinicalTrials.gov registry record
Trans-pulmonary Biomarkers in Pulmonary Hypertension
A clinical trial of Pulmonary Hypertension, sponsored by Vanderbilt University.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT01961232 is a study of Pulmonary Hypertension that is active but no longer recruiting, run by Vanderbilt University. The registered enrollment target is 100 participants, below the 612-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01961232, a study of Pulmonary Hypertension, is active but no longer recruiting, sponsored by Vanderbilt University.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are testing whether the addition of Pulmonary Hypertension-related biomarkers, measured across the pulmonary circulation, to the standard hemodynamic evaluation for Pulmonary Hypertension will lead to more informed choices of Pulmonary Hypertension therapy and improved patient outcomes.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-08 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01961232
The ClinicalTrials.gov registry entry for NCT01961232 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 612-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (84% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT01961232 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01961232 about?
NCT01961232 is a clinical study titled "Trans-pulmonary Biomarkers in Pulmonary Hypertension". The investigators are testing whether the addition of Pulmonary Hypertension-related biomarkers, measured across the pulmonary circulation, to the standard hemodynamic evaluation for Pulmonary Hypertension will lead to more informed choices of Pulmonary Hypertension therapy and improved patient outc...
What is the current status of trial NCT01961232?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2013-08. Estimated completion is 2027-06.
What conditions does trial NCT01961232 study?
This clinical trial studies the following conditions: Pulmonary Hypertension.
Who is sponsoring clinical trial NCT01961232?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01961232 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.